Planning Committee

Planning Committee

The Progeria Research Foundation
10th Anniversary Workshop on Progeria

“From Bench to Bedside in a Decade”
April 11-13, 2010 • Seaport Hotel • Boston, MA

 

 


It is PRF's privilege tothank the workshop organizers
for their insightful and invaluable contributions to this event
(left to right):
Bob Goldman, Frank Rothman, Leslie Gordon, Tom Misteli and George Martin
.

MEMBERS OF THE PLANNING COMMITTEE

Organizers
Leslie B. Gordon, MD, PhD
Associate Professor of Pediatrics Research, Warren Alpert Medical School of Brown University and Dept. of Pediatrics, Hasbro Children’s Hospital, Providence, RI; Medical Director, The Progeria Research Foundation, Peabody, MA

Dr. Gordon, the Founder of The Progeria Research Foundation, has published extensively on Progeria. She is the co-PI of the first and second HGPS clinical drug trials at Children’s Hospital Boston.

Frank G. Rothman, PhDProfessor of Biology and Provost, Emeritus, Brown Univ.

Dr. Rothman has served as the Dean of Biology at Brown University and taught courses on the Biology of Aging. He was a member of the PRF Genetics Consortium and has contributed a peer-reviewed publication and co-authored a review chapter and a Meeting Report chapter to the Progeria field.

Advisory Board
Robert D. Goldman, PhD
Stephen Walter Professor, Chairman, Dept. of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL

Dr. Goldman is a former president of the ASCB and a pioneer in the field of lamins. His research focuses on the structure and function of cytoskeletal systems. He has published landmark papers on Progeria biology and continues to actively study Progeria in his laboratory.

George M. Martin, MDProfessor (Emeritus – active), Department of Pathology, Director (Emeritus), Alzheimer’s Research Center, University of Washington, Seattle, WA

Dr. Martin is a pioneer in the fields of aging and Werner’s syndrome. His research includes studying the genetic approaches to elucidate the pathobiology of aging and age-related diseases. He is a former president of the Gerontological Society of North America.

Thomas Misteli, PhDSenior Investigator and Head, Cell Biology of Genomes Group, National Cancer Institute, National Institutes of Health, Bethesda, MD

Dr. Misteli and his team are elucidating the cell biological basis of HGPS and are developing novel therapeutic strategies for HGPS based on correction of the disease causing pre-mRNA splicing defect.

Coordinator
Susan L. Rosenblatt
Ms. Rosenblatt has served as PRF’s Executive Assistant and Volunteer Coordinator for 6 ½ years and has coordinated the scientific workshops from 2004-2007.

quick links

Donate Now
Now more than ever, your contribution makes a difference.

Sign Up For Our Mailing List!